首页|A β-lactamase-activatable photosensitizer for the treatment of resistant bacterial infections

A β-lactamase-activatable photosensitizer for the treatment of resistant bacterial infections

扫码查看
Antibacterial agent of activatable photosensitizer not only has the advantages of traditional photosensi-tizers,such as good curative effect and low resistance,but also has better selectivity for bacteria and lower toxicity to normal tissues.Limited reports of activatable photosensitizer can be used to treat drug-resistant bacteria.In order to meet this challenge,we designed and synthesized an activatable photo-sensitizer(Ce-OHOA),which can not only selectively identify methicillin-resistant Staphylococcus aureus(MRSA)with high expression of β-lactamase by fluorescence imaging,but also kill MRSA with less than 10 times the concentration and 10 times the irradiation dose of CySG-2 reported.Ce-OHOA not only com-bines the dual functions of fluorescence diagnosis and photodynamic therapy,but also selectively acts on bacteria with high expression of β-lactamase and has little toxicity to normal cells.We expect that the study of this activating photosensitizer will provide a new solution for antibacterial photodynamic ther-apy(aPDT)of drug-resistant bacteria.

Activatable photosensitizerMRSAβ-LactamaseFluorescence imagingaPDT

Zhipeng Li、Qincong Feng、Jianliang Shen

展开 >

National Engineering Research Center of Ophthalmology and Optometry,Eye Hospital,Wenzhou Medical University,Wenzhou 325027,China

Zhejiang Engineering Research Center for Tissue Repair Materials,Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China

2024

中国化学快报(英文版)
中国化学会

中国化学快报(英文版)

CSTPCD
影响因子:0.771
ISSN:1001-8417
年,卷(期):2024.35(11)